KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardant Health (GH) Income from Non-Controlling Interests (2018 - 2021)

Guardant Health's Income from Non-Controlling Interests history spans 4 years, with the latest figure at $18.6 million for Q4 2021.

  • On a quarterly basis, Income from Non-Controlling Interests rose 2557.14% to $18.6 million in Q4 2021 year-over-year; TTM through Sep 2022 was $18.6 million, a 520.0% increase, with the full-year FY2021 number at $20.9 million, up 178.67% from a year prior.
  • Income from Non-Controlling Interests hit $18.6 million in Q4 2021 for Guardant Health, up from $2.3 million in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for GH hit a ceiling of $18.6 million in Q4 2021 and a floor of -$4.1 million in Q1 2020.
  • Historically, Income from Non-Controlling Interests has averaged $3.1 million across 4 years, with a median of $1.6 million in 2018.
  • Biggest five-year swings in Income from Non-Controlling Interests: crashed 187.23% in 2020 and later skyrocketed 2557.14% in 2021.
  • Tracing GH's Income from Non-Controlling Interests over 4 years: stood at -$150000.0 in 2018, then skyrocketed by 2166.67% to $3.1 million in 2019, then tumbled by 77.42% to $700000.0 in 2020, then skyrocketed by 2557.14% to $18.6 million in 2021.
  • Business Quant data shows Income from Non-Controlling Interests for GH at $18.6 million in Q4 2021, $2.3 million in Q1 2021, and $700000.0 in Q4 2020.